Reports
Reports
Sale
The global uterine manipulation devices market size was valued at USD 322.57 million in 2023, driven by the rising prevalence of gynaecological surgeries like hysterectomy across the globe. The market is expected to grow at a CAGR of 5.9% during the forecast period of 2024-2032, with the values likely to rise from USD 341.60 million in 2024 to USD 540.37 million by 2032.
Uterine manipulators are devices used to move, adjust, or reposition a patient’s uterus during a medical procedure. Such procedures include laparoscopic gynecologic surgeries like hysterectomy (uterus removal). It is also used in the identification of vaginal fornixes and sealing the vagina during a hysterectomy.
Uterine manipulation devices are commonly applied in minimally invasive procedures like laparoscopy. It constitutes a proximal handle (remains outside) and a distal or working handle (inserted into the body).
With the rising number of laparoscopic and robot-assisted gynecological procedures, the uterine manipulation devices market demand has observed a significant surge in the historic period. The emphasis on decreasing surgical errors, fatigue levels, and improving the margin of safety and efficiency in gynecologic surgery has propelled the market growth.
Minimally invasive and open abdominal radical hysterectomy have been the most effective surgical methods to treat early-stage cervical cancer in women. As a result, advanced uterine manipulators have emerged in the market, that allow better visualization and exposure to the area that is useful in cases of adhesions or endometriosis. The RUMI II system, ZUMI/HUMI, and K-UMI devices, Advincula Arch, are some well-known names used in surgeries.
In recent years, automation and innovation in the healthcare industry have led to significant developments in uterine manipulation devices. For instance, the Fisabio Foundation, along with researchers from General University Hospital of Castelló, have developed an atraumatic uterine manipulator that facilitates minimally invasive gynecologic surgeries. The major area of focus has been improving the surgical technique without damaging initial uterine cervical tumours with a suction mechanism. This technology has been validated at a pilot scale in the lab setting and will be applied in the industrial manufacturing of uterine manipulators. Hence, we can expect uterine manipulation devices market growth in the forecast period.
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Uterine cancer is the fourth most commonly occurring cancer in women, estimated to affect approximately 66,200 women in the United States itself. Hence, the prevalence of hysterectomies has increased in the area, adding further growth to the uterine manipulation devices market share. The presence of an established infrastructure also drives significant growth owing to several technological and research breakthroughs in the field.
Asia Pacific is expected to witness rapid growth in the uterine manipulators market. This can be attributed to several awareness programs started by the government that talk about the early detection of cancers and the emphasis on improving the reproductive health of women in general. Moreover, the sheer size of Asia’s population, along with easy accessibility to environmental and academic resources, has also resulted in major investments from top healthcare entities. This is set to bring some major developments in the field, resulting in substantial growth in the area.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Uterine Manipulation Devices Market Overview
3.1 Global Uterine Manipulation Devices Market Historical Value (2017-2023)
3.2 Global Uterine Manipulation Devices Market Forecast Value (2024-2032)
4 Global Uterine Manipulation Devices Market Landscape
4.1 Global Uterine Manipulation Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Uterine Manipulation Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
5 Global Uterine Manipulation Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Uterine Manipulation Devices Market Segmentation
6.1 Global Uterine Manipulation Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Uterine Manipulators
6.1.3 Uterine Cannulas
6.1.4 Uterine Tenaculum
6.2 Global Uterine Manipulation Devices Market by Applications
6.2.1 Market Overview
6.2.2 Total Laparoscopy Hysterectomy (TLH)
6.2.3 Laparoscopic Supracervical Hysterectomy (LSH)
6.2.4 Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
6.2.5 Sacro Colpopexy
6.2.6 Others
6.3 Global Uterine Manipulation Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialized Gynaecology Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Others
6.4 Global Uterine Manipulation Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Uterine Manipulation Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Uterine Manipulation Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Uterine Manipulation Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Uterine Manipulation Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Uterine Manipulation Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Conkin Surgical Instruments Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Johnson and Johnson
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 CooperSurgical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 B. Braun Medical Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 KARL STORZ GmbH & Co. KG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 CONMED Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 RUDOLF Medical GmbH + Co. KG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 LiNA Medical ApS
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Richard Wolf GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Utah Medical Products, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Purple Surgical
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Clinical Innovations, LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Bissinger Medizintechnik
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 The O.R. Company
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 LSI Solutions, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Uterine Manipulation Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 322.57 million in 2023, driven by the incidence of hysterectomies and other gynaecological procedures globally.
The market is anticipated to grow at a CAGR of 5.9% during the forecast period of 2024-2032, likely to reach a market value of USD by 540.37 million by 2032.
The market demand for uterine manipulation devices has increased with the focus on decreasing surgical errors, fatigue levels while improving safety and efficiency in gynecological surgeries.
Technically advanced devices that facilitate minimally invasive surgeries and improved visualisation are being widely used in the market. For example, the atraumatic uterine manipulators have been developed recently, based on suction mechanisms.
Products include uterine manipulators, cannulas and tenaculum.
These devices find wide applications in total laparoscopy hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), laparoscopically assisted vaginal hysterectomy (LAVH), and sacro colpopexy, among others.
Hospitals, specialized gynaecology clinics, and ambulatory surgical centres, among others are the key end users.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are Conkin Surgical Instruments Ltd., Johnson and Johnson, CooperSurgical, Inc., B. Braun Medical Ltd., KARL STORZ GmbH & Co. KG, CONMED Corporation, RUDOLF Medical GmbH + Co. KG, LiNA Medical ApS, Richard Wolf GmbH, Utah Medical Products, Inc., Purple Surgical, LLC, Bissinger Medizintechnik , The O.R. Company and LSI Solutions, Inc., and Clinical Innovations.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.